Outcome of Graves disease after radioiodine therapy [7];Evolución de la enfermedad de Graves tras tratamiento con radioyodo

Anales de Medicina Interna

Volumn 22, Issue 6, 2005, Pages 303-304

  Marti J ^a   Anton E ^a   Laborda, E ^b   Santesteban, P ^b  

^a HOSPITAL DE ZUMÁRRAGA   (Spain)

^b Instituto Oncologico de Guipuzcoa   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; PROPYLTHIOURACIL; RADIOACTIVE IODINE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LETTER; MALE; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 23644435313     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Andrade VA, Gross JL, Maia AL. Yodo radioativo no manejo do hipertireodismo da doença de Graves. Arq Bras Endocrinol Metab 2004; 48: 159-165.
2. Herrera MT, Ollero D, Cruces EM, Lillo ME, Gonzalo MA, et al. Evolución a largo plazo tras tratamiento con I-131 en el Hipertiroidismo. Endocrinol Nutr 2004; 51 (Supl. 1): 51.
3. Yamashita Y, Yamane K, Tamura T, Okubo M, Kohno N. Onset age is associated with outcome of radioiodine therapy in Graves' disease. Endocrin J 2004; 51: 127-132.
4. Cooper DS. Antithyroid drugs in the management of patients with Graves' disease: An evidence-based approach to therapeutic controversies. J Clin Endocrinol Metab 2003; 88: 3474-3481.
5. Leslie WD, Ward L, Salamon EA, Ludwing S, Rowe RC, et al. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003; 88: 978-983.
6. Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, y cols. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol 2004; 61: 641-648.